FDA
approval
· 2021-01-14
FDA Approved: RASAGILINE MESYLATE — Supplemental Application (Avet Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Rasagiline Mesylate filed by Avet Pharmaceuticals, approving a generic version of the Parkinson's disease medica…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RASAGILINE MESYLATE (RASAGILINE MESYLATE)